Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management

Respirology

Volumn 15, Issue 4, 2010, Pages 683-690

  Cowan, Douglas C ^a   Hewitt, Richard S ^a   Cowan, Jan O ^a   Palmay, Rochelle ^a   Williamson, Avis ^a   Lucas, Samuel J E ^b   Murrell, Carissa J ^b   Thomas, Kate N ^b   Taylor, D Robin ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Airway hyperresponsiveness; Asthma; Exercise induced wheeze; Exhaled nitric oxide; Mannitol

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; FLUTICASONE; FLUTICASONE PROPIONATE; FORMOTEROL; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; MANNITOL; MONTELUKAST; NITRIC OXIDE; ACETIC ACID DERIVATIVE; ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; ETHANOLAMINE DERIVATIVE; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRONCHOSPASM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXERCISE INDUCED BRONCHOCONSTRICTION; EXERCISE INDUCED WHEEZE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT DURATION; WHEEZING; ABNORMAL RESPIRATORY SOUND; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; DRUG EFFECTS; EXERCISE; FORCED EXPIRATORY VOLUME; MIDDLE AGED; YOUNG ADULT;

ACETATES; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CHILD; CROMOLYN SODIUM; ETHANOLAMINES; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MANNITOL; MIDDLE AGED; NITRIC OXIDE; QUINOLINES; RESPIRATORY SOUNDS; YOUNG ADULT;

EID: 77951735251     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01740.x     Document Type: Article

References (49)

1. Henriksen AH, Tveit KH, Holmen TL et al. A study of the association between exercise-induced wheeze and exercise versus methacholine-induced bronchoconstriction in adolescents. Pediatr. Allergy Immunol. 2002 13 : 203 208.
2. ElHalawani SM, Ly NT, Mahon RT et al. Exhaled nitric oxide as a predictor of exercise-induced bronchoconstriction. Chest 2003 124 (2 639 643.
3. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J. Allergy Clin. Immunol. 2008 122 : 238 246 quiz 247-8.
4. Anderson SD, Argyros GJ, Magnussen H et al. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br. J. Sports Med. 2001 35 : 344 347.
5. Holzer K, Anderson SD, Chan HK et al. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am. J. Respir. Crit. Care Med. 2003 167 : 534 537.
6. Anderson SD, Seale JP, Rozea P et al. Inhaled and oral salbutamol in exercise-induced asthma. Am. Rev. Respir. Dis. 1976 114 : 493 500.
7. Woolley M, Anderson SD, Quigley BM. Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma. Chest 1990 97 (1 39 45.
8. Kemp JP, Dockhorn RJ, Busse WW et al. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am. J. Respir. Crit. Care Med. 1994 150 (6 Pt 1 1612 1615.
9. Henriksen JM, Agertoft L, Pedersen S. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. J. Allergy Clin. Immunol. 1992 89 : 1176 1182.
10. de Benedictis FM, Tuteri G, Bertotto A et al. Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children. J. Allergy Clin. Immunol. 1994 94 : 684 688. (Pubitemid 24326149)
11. Tullett WM, Tan KM, Wall RT et al. Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma. Thorax 1985 40 : 41 4.
12. Patel KR, Wall RT. Dose-duration effect of sodium cromoglycate aerosol in exercise-induced asthma. Eur. J. Respir. Dis. 1986 69 : 256 260.
13. Leff JA, Busse WW, Pearlman D et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N. Engl. J. Med. 1998 339 : 147 152.
14. Kim JH, Lee SY, Kim HB et al. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction. Pediatr. Pulmonol. 2005 39 : 162 166.
15. Vathenen AS, Knox AJ, Wisniewski A et al. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax 1991 46 : 811 816.
16. Hofstra WB, Neijens HJ, Duiverman EJ et al. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr. Pulmonol. 2000 29 : 415 423.
17. Jonasson G, Carlsen KH, Hultquist C. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatr. Allergy Immunol. 2000 11 : 120 125.
18. Nelson JA, Strauss L, Skowronski M et al. Effect of long-term salmeterol treatment on exercise-induced asthma. N. Engl. J. Med. 1998 339 : 141 146.
19. Ramage L, Lipworth BJ, Ingram CG et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir. Med. 1994 88 : 363 368.
20. Taylor DR. The beta-agonist saga and its clinical relevance: on and on it goes. Am. J. Respir. Crit. Care Med. 2009 179 : 976 978.
21. Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am. Rev. Respir. Dis. 1983 128 : 993 997.
22. Henriksen JM. Effect of inhalation of corticosteroids on exercise induced asthma: randomised double blind crossover study of budesonide in asthmatic children. Br. Med. J. (Clin. Res. Ed.) 1985 291 (6490 248 249.
23. Waalkens HJ, van Essen-Zandvliet EE, Gerritsen J et al. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur. Respir. J. 1993 6 : 652 656.
24. Berry MA, Shaw DE, Green RH et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin. Exp. Allergy 2005 35 : 1175 1179.
25. Yoshikawa T, Shoji S, Fujii T et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur. Respir. J. 1998 12 (4 879 884.
26. Duong M, Subbarao P, Adelroth E et al. Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 2008 133 (2 404 411.
27. Buchvald F, Hermansen MN, Nielsen KG et al. Exhaled nitric oxide predicts exercise-induced bronchoconstriction in asthmatic school children. Chest 2005 128 (4 1964 1967.
28. Smith AD, Cowan JO, Brassett KP et al. Exhaled nitric oxide: a predictor of steroid response. Am. J. Respir. Crit. Care Med. 2005 172 : 453 459.
29. Kharitonov SA, Gonio F, Kelly C et al. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur. Respir. J. 2003 21 : 433 438.
30. Joint Statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am. J. Respir. Crit. Care Med. 2005 171 : 912 930.
31. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur. Respir. J. 2005 26 : 319 338.
32. Juniper EF, O'Byrne PM, Guyatt GH et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999 14 (4 902 907.
33. Anderson SD, Brannan JD. Methods for 'indirect' challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin. Rev. Allergy Immunol. 2003 24 (1 27 54.
34. Anderson SD, Brannan J, Spring J et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am. J. Respir. Crit. Care Med. 1997 156 (3 Pt 1 758 765.
35. Crapo RO, Casaburi R, Coates AL et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am. J. Respir. Crit. Care Med. 2000 161 (1 309 329.
36. Wilson RC, Jones PW. Long-term reproducibility of Borg scale estimates of breathlessness during exercise. Clin. Sci. (Lond.) 1991 80 : 309 312.
37. Dahlen B, O'Byrne PM, Watson RM et al. The reproducibility and sample size requirements of exercise-induced bronchoconstriction measurements. Eur. Respir. J. 2001 17 : 581 588.
38. Juniper EF, Svensson K, Mork AC et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir. Med. 2005 99 : 553 558.
39. Brannan JD, Anderson SD, Gomes K et al. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am. J. Respir. Crit. Care Med. 2001 163 (6 1420 1425.
40. Anderson SD, Rodwell LT, Du Toit J et al. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991 100 (5 1254 1260.
41. Villaran C, O'Neill SJ, Helbling A et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J. Allergy Clin. Immunol. 1999 104 (3 Pt 1 547 553.
42. Coreno A, Skowronski M, Kotaru C et al. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J. Allergy Clin. Immunol. 2000 106 : 500 506.
43. Stelmach I, Grzelewski T, Majak P et al. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J. Allergy Clin. Immunol. 2008 121 : 383 389.
44. Petersen R, Agertoft L, Pedersen S. Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma. Eur. Respir. J. 2004 24 : 932 937.
45. Szefler SJ, Martin RJ, King TS et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol. 2002 109 : 410 418.
46. Brannan JD, Koskela H, Anderson SD et al. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002 7 (1 37 44.
47. Koskela HO, Hyvarinen L, Brannan JD et al. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 2003 124 (4 1341 1349.
48. Hancox RJ, Subbarao P, Kamada D et al. Beta2-agonist tolerance and exercise-induced bronchospasm. Am. J. Respir. Crit. Care Med. 2002 165 : 1068 1070.
49. Shaw DE, Berry MA, Thomas M et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2007 176 : 231 237.